BioPortfolio - Life Sciences: Liberate to innovate

Author:

Martin (Marty) Magazzolo, Global Practice Director, Software Solutions Group, with CSC Life Sciences, has more than 20 years of experience in the field of information technology, with 18 of those having been spent in the life sciences.

Little by little, the pharma industry is learning that the keys to strategic advantage against the backdrop of difficult market conditions are focus and delegation — even if it means entrusting precious data assets to external providers. Martin Magazzolo, global practice director at CSC Life Sciences’ Software Solutions Group, finds that, buoyed by positive experiences with managed information technology infrastructure services, life sciences companies are now increasingly attracted to content-as-a-service solutions, which offer them new freedom to focus their internal resources where those resources are needed most.

The life sciences industry is notorious for its conservative outlook and has traditionally preciously guarded its information-based assets as a means of preserving competitive edge and customer safety. But times have changed, and with markets showing no immediate sign of recovery and competitive pressures fiercer than ever, pharma companies have found they must rethink their business models if they want to secure their futures. Read more.